Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tremfya (guselkumab)
Marketing
UCB continues reign as largest drug ad spender
UCB’s immunology drug Bimzelx has topped the pharma drug ad spending charts for the third month in a row.
Ben Adams
Nov 10, 2026 4:34am
UCB’s Bimzelx leads pharma’s Q3 drug ad spend
Oct 27, 2026 12:56pm
UCB’s Bimzelx claims August’s top pharma ad spending spot
Sep 4, 2026 9:18am
AbbVie’s Skyrizi leading drug in pharma’s ad spending league
Aug 7, 2026 9:45am
With $5.5B sales, AbbVie's Skyrizi matches Humira's best quarter
Jul 31, 2026 11:18am
J&J’s Tremfya remains on top in Q2 pharma ad spending league
Jul 21, 2026 9:10am
